Ravi Upasani teaches research and analysis of patent information pertaining to pharmaceutical.
Ravi is a Biopharmaceutical Intellectual Property professional with extensive background and expertise in devising and implementing patent filing strategies that protect inventions and emerging technologies. Possess around 10 years of experience in IP, and 15 years of experience in medicinal chemistry.
Experience includes:
- 8 Years of experience in directing IP departments
- Drafting, filing and prosecuting U.S. and foreign patent applications
- 150 small molecule composition of matter patent applications
- 10 US applications issued/allowed
- Several in person “Examiner’s Interview”
- Conducting structure-based IP searches and performing freedom-to-operate (FTO) analysis on small molecule drug candidates
- Developing and implementing
- effective patent filing strategy based on SAR (Structure-Activity Relationship) and bioisosterism
- effective and pre-emptive strategies with respect to potential third party conflicting IP
- Managing all IP aspects of collaboration with big pharma (Pfizer, AstraZeneca, and Roche)
- Performing Due Diligence of third party IP for in-licensing and collaboration activities
- Providing strategic intellectual property advice and intellectual property portfolio management (>400 patents and patent applications; US and foreign counterparts)
- Providing research and analysis of patent information pertaining to pharmaceutical projects Patent lifecycle management (patent term extension)
- Conducting IP analysis for licensing and M&A activities
Ravi has a Ph.D. in Synthetic Organic Chemistry from University of Bombay, M.Sc., Organic Chemistry and B.Sc., Chemistry from University of Bombay. He is Registered Patent Agent (Reg. No. 53,712)
